Defence Therapeutics Inc.
Defence Therapeutics Inc.
CSE Index:
CSE CompositeCurrency:
CAD Defence Therapeutics Inc. is a biotechnology company engaged in the business of research and development, focusing on enhancing delivery of tumor-/ and infectious disease-specific therapeutics. The principal business carried on is the development of a biological drug enhancer platform that improves the efficacy and safety of a multitude of biological/biosimilar-based pharmaceuticals used in the treatment of cancer and infectious diseases.
Defence Therapeutics Inc. (DTC)
1.05
0.00 (0.00%)
Defence Therapeutics Inc (DTC)
*Financial charts powered by Quotemedia.com. All right reserved. View the Terms of Use. Data delayed 15 minutes unless indicated.
Bid Size
1,000
Bid Price
1.07
Ask Price
1.11
Ask Size
200
Volume
38,250
Last Price
1.05
Tick
Net Change
Prev Close
1.05
Open
1.10
Day High
1.12
Day Low
1.05
52 Week High
1.74
52 Week Low
0.48
*Note: Bid Size and Ask Size fields are displayed as actual quantities
Bid Size
0
Bid Price
0.00
Ask Price
0.00
Ask Size
0
Volume
0
Last Price
Tick
Net Change
Prev Close
Open
0.00
Day High
0.00
Day Low
0.00
52 Week High
52 Week Low
*Note: Bid Size and Ask Size fields are displayed as actual quantities
Bid Size
1,000
Bid Price
1.07
Ask Price
1.11
Ask Size
200
Volume
38,250
Last Price
1.05
Tick
Net Change
Prev Close
1.05
Open
1.10
Day High
1.12
Day Low
1.05
52 Week High
1.74
52 Week Low
0.48
*Note: Bid Size and Ask Size fields are displayed as actual quantities
Bid Size
0
Bid Price
0.00
Ask Price
0.00
Ask Size
0
Volume
0
Last Price
Tick
Net Change
Prev Close
Open
0.00
Day High
0.00
Day Low
0.00
52 Week High
52 Week Low
*Note: Bid Size and Ask Size fields are displayed as actual quantities
| Bid Broker | Bid Size | Bid Price | Ask Price | Ask Size | Ask Broker |
|---|---|---|---|---|---|
| TD Securities Inc. | 1,000 | 1.07 | 1.11 | 200 | TD Securities Inc. |
| TD Securities Inc. | 2,000 | 1.01 | 1.19 | 2,500 | Anonymous |
| TD Securities Inc. | 1,000 | 0.97 | 1.21 | 1,000 | Anonymous |
| National Bank Financial Inc. | 1,800 | 0.97 | 1.22 | 6,000 | CIBC World Markets Inc. |
| CIBC World Markets Inc. | 6,000 | 0.96 | 1.30 | 5,000 | CIBC World Markets Inc. |
| Scotia Capital Inc. | 50,000 | 0.95 | 1.39 | 1,000 | CIBC World Markets Inc. |
| Leede Jones Gable | 5,200 | 0.93 | 1.41 | 200 | Anonymous |
| Scotia Capital Inc. | 10,000 | 0.92 | 1.66 | 5,600 | TD Securities Inc. |
| Leede Jones Gable | 10,000 | 0.90 | 1.95 | 1,000 | Anonymous |
| TD Securities Inc. | 2,500 | 0.84 | 2.00 | 10,000 | RBC Capital Markets |
| Bid Broker | Bid Size | Bid Price | Ask Price | Ask Size | Ask Broker |
|---|---|---|---|---|---|
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 |
| Bid Count | Bid Size | Bid Price | Ask Price | Ask Size | Ask Count |
|---|---|---|---|---|---|
| 1 | 1,000 | 1.07 | 1.11 | 200 | 1 |
| 1 | 2,000 | 1.01 | 1.19 | 2,500 | 1 |
| 2 | 2,800 | 0.97 | 1.21 | 1,000 | 1 |
| 1 | 6,000 | 0.96 | 1.22 | 6,000 | 1 |
| 1 | 50,000 | 0.95 | 1.30 | 5,000 | 1 |
| Bid Count | Bid Size | Bid Price | Ask Price | Ask Size | Ask Count |
|---|---|---|---|---|---|
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| Date/Time | Price | Change | Volume | Buyer | Seller | Venue |
|---|---|---|---|---|---|---|
| Apr 1, 19:12 | 1.08 | 0.03 | 300 | Canaccord Capital Corporation | RBC Capital Markets | CSE |
| Apr 1, 19:12 | 1.05 | 0.00 | 3,500 | National Bank Financial Inc. | RBC Capital Markets | CSE |
| Apr 1, 17:54 | 1.08 | 0.03 | 2,000 | Canaccord Capital Corporation | Research Capital Corporation | CSE |
| Apr 1, 17:17 | 1.08 | 0.03 | 5,300 | Canaccord Capital Corporation | Anonymous | CSE |
| Apr 1, 16:15 | 1.12 | 0.07 | 800 | CIBC World Markets Inc. | Anonymous | CSE |
Company Info
Address
1615, 200 Burrard St.
Vancouver, BC V6C 3L6
CanadaPhone
604-753-8834Email
sebas.plouffe@gmail.comWebsite
https://defencetherapeutics.comListing date
Friday, May 7, 2021Transfer Agent
Computershare Investor Services Inc.SEDAR Information
Filing Type
Any
News Releases
Material Change Report
Management's Discussion & Analysis
Financial Statements
Timeframe
1 week1 month3 month6 month1 yearAll Time
Defence Therapeutics Inc
Date:
Dec 5, 2024
Defence Therapeutics Inc
Date:
Dec 4, 2024
Defence Therapeutics Inc
Date:
Nov 26, 2024
Defence Therapeutics Inc
Date:
Nov 7, 2024
Defence Therapeutics Inc
Date:
Sep 20, 2024
Defence Therapeutics Inc
Date:
Sep 20, 2024
Defence Therapeutics Inc
Date:
Apr 10, 2024
Defence Therapeutics Inc
Date:
Apr 1, 2024
Defence Therapeutics Inc
Date:
Feb 8, 2024
Defence Therapeutics Inc
Date:
Oct 27, 2023
Defence Therapeutics Inc
Date:
Oct 27, 2023
Defence Therapeutics Inc
Date:
Oct 10, 2023
Defence Therapeutics Inc
Date:
Oct 24, 2022
Defence Therapeutics Inc
Date:
Oct 24, 2022
Defence Therapeutics Inc
Date:
Nov 23, 2021
Defence Therapeutics Inc
Date:
Nov 23, 2021
Defence Therapeutics Inc
Date:
Nov 23, 2021
Defence Therapeutics Inc
Date:
Oct 27, 2021
Defence Therapeutics Inc
Date:
Oct 27, 2021
Defence Therapeutics Inc
Date:
Apr 30, 2021
Defence Therapeutics Inc
Date:
Apr 30, 2021
Defence Therapeutics Inc
Date:
Apr 30, 2021
Defence Therapeutics Inc
Date:
Apr 30, 2021
Defence Therapeutics Inc
Date:
Feb 5, 2021
Defence Therapeutics Inc
Date:
Jan 4, 2021
Defence Therapeutics Inc
Date:
Oct 16, 2020
Company Info
Address
1615, 200 Burrard St.
Vancouver, BC V6C 3L6
CanadaPhone
604-753-8834Email
sebas.plouffe@gmail.comWebsite
https://defencetherapeutics.comListing date
Friday, May 7, 2021Transfer Agent
Computershare Investor Services Inc.Capitalization
Issued & Outstanding:
54725370Reserved for Issuance:
6437785Company Officers
P. Joseph Meagher, Chief Financial Officer
Sebastien Plouffe, President and Chief Executive Officer
Arnab De, CFO
Bulletins
06/05/2021
2021-0505 – New Listing - Defence Therapeutics Inc. (DTC)
Le 6 mai/May 2021
The common shares of Defence Therapeutics Inc., have been approved for listing on the CSE.
Listing and disclosure documents will be available at www.thecse.com on the trading date.
